Abstract
In activated mouse natural killer (NK) cells, the NKG2D receptor associates with two intracellular adaptors, DAP10 and DAP12, which trigger phosphatidyl inositol 3 kinase (PI3K) and Syk family protein tyrosine kinases, respectively. Here we show that cytotoxicity, but not cytokine production, is triggered by NKG2D in activated NK cells lacking either DAP12 or the Syk family members Syk and ZAP70. Inhibition of PI3K blocks this cytotoxicity, suggesting that the DAP10-PI3K pathway is sufficient to initiate NKG2D-mediated killing of target cells. Our results highlight signaling divergence in the effector functions of NKG2D and indicate that alternative associations between a receptor and its adaptors may provide a single receptor with a dual 'on-switch', giving mouse NK cells more choices through which to trigger cytotoxicity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Leibson, P.J. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6, 655–661 (1997).
Long, E.O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17, 875–904 (1999).
Colucci, F., Di Santo, J.P. & Leibson, P.J. Natural killer cell activation in mice and men: different triggers for similar weapons? Nat. Immunol. 3, 807–813 (2002).
Lanier, L.L. On guard—activating NK cell receptors. Nat. Immunol. 2, 23–27 (2001).
Colucci, F. et al. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat. Immunol. 3, 288–294 (2002).
Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727–729 (1999).
Diefenbach, A., Jamieson, A.M., Liu, S.D., Shastri, N. & Raulet, D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1, 119–126 (2000).
Cosman, D. et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123–133 (2001).
Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721–727 (2000).
Carayannopoulos, L.N., Naidenko, O.V., Fremont, D.H. & Yokoyama, W.M. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169, 4079–4083 (2002).
Cerwenka, A. & Lanier, L.L. Ligands for natural killer cell receptors: redundancy or specificity. Immunol. Rev. 181, 158–169 (2001).
Diefenbach, A., Jensen, E.R., Jamieson, A.M. & Raulet, D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413, 165–171 (2001).
Cerwenka, A., Baron, J.L. & Lanier, L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I–bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98, 11521–11526 (2001).
Wu, J. et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285, 730–732 (1999).
Jamieson, A.M. et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17, 19–29 (2002).
Wu, J., Cherwinski, H., Spies, T., Phillips, J.H. & Lanier, L.L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192, 1059–1068 (2000).
Gilfillan, S., Ho, E.L., Cella, M., Yokoyama, W.M. & Colonna, M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3, 1150–1155 (2002).
Diefenbach, A. et al. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3, 1142–1149 (2002).
Long, E.O. Versatile signaling through NKG2D. Nat. Immunol. 3, 1119–1120 (2002).
Turner, M. et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298–302 (1995).
Idris, A.H. et al. The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc. Natl. Acad. Sci. USA 96, 6330–6335 (1999).
Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B. & Lanier, L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323–1326 (2002).
Biron, C.A., Nguyen, K.B., Pien, G.C., Cousens, L.P. & Salazar-Mather, T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189–220 (1999).
Karre, K., Ljunggren, H.G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675–678 (1986).
Glas, R. et al. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J. Exp. Med. 191, 129–138 (2000).
Billadeau, D.D., Upshaw, J.D., Schoon, R.A., Dick, C.J. & Leibson, P.J. NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway. Nat. Immunol., advance online publication, 11 May 2003 (doi:10.1038/ni929).
Karre, K. MHC gene control of the natural killer system at the level of the target and the host. Semin. Cancer Biol. 2, 295–309 (1991).
Groh, V. et al. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2, 255–260 (2001).
Hald, J., Rasmussen, N. & Claesson, M.H. Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck. Cancer Immunol. Immunother. 41, 243–250 (1995).
Ogasawara, K., Yoshinaga, S.K. & Lanier, L.L. Inducible costimulator costimulates cytotoxic activity and IFN-γ production in activated murine NK cells. J. Immunol. 169, 3676–3685 (2002).
Martin-Fontecha, A., Assarsson, E., Carbone, E., Karre, K. & Ljunggren, H.G. Triggering of murine NK cells by CD40 and CD86 (B7-2). J. Immunol. 162, 5910–5916 (1999).
Hayakawa, Y. et al. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. J. Immunol. 169, 5377–5381 (2002).
Chuang, S.S., Kumaresan, P.R. & Mathew, P.A. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways. J. Immunol. 167, 6210–6216 (2001).
Colucci, F. et al. Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms. J. Exp. Med. 193, 1413–1424 (2001).
Colucci, F. et al. Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J. Immunol. 162, 2761–2765 (1999).
Kadlecek, T.A. et al. Differential requirements for ZAP-70 in TCR signaling and T cell development. J. Immunol. 161, 4688–4694 (1998).
Spanopoulou, E. et al. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev. 8, 1030–1042 (1994).
Bakker, A.B. et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13, 345–353 (2000).
Ogasawara, K. et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18, 41–51 (2003).
Acknowledgements
We thank A. Weiss and T. Kadlecek for Zap70−/− mice; E. Corcuff, O. Richard and T. Chen for help; A. Caraux for reading the manuscript; and P. Leibson and D. Billadeau for discussions and for sharing unpublished data. This work was supported by grants from the Pasteur Institute, Ligue Nationale Contre le Cancer, Association pour la Recherche sur le Cancer, Institut National de la Santé et de la Recherche Medicale (to F.C. and J.P.D.) and the Medical Research Council (to V.J.L.T.), and grant R01 CA89294 from the National Institutes of Health (to L.L.L.). S.Z. is supported by a grant from Ligue Nationale Contre le Cancer; J.A.H. is supported by a grant from Irvington Institute for Immunological Research; K.O. is supported by Human Frontier Science Program Long-term Fellowship; E.S. is supported by the European Molecular Biology Organization; and L.L.L. is a Research Professor of the American Cancer Society.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Zompi, S., Hamerman, J., Ogasawara, K. et al. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat Immunol 4, 565–572 (2003). https://doi.org/10.1038/ni930
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni930
This article is cited by
-
NKG2D Triggers Cytotoxicity in Murine Epidermal γδ T Cells via PI3K-Dependent, Syk/ZAP70-Independent Signaling Pathway
Journal of Investigative Dermatology (2014)
-
Signaling by Fyn-ADAP via the Carma1–Bcl-10–MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells
Nature Immunology (2013)
-
Natural killer cells in patients with severe chronic fatigue syndrome
Autoimmunity Highlights (2013)
-
Activating and inhibitory receptors of natural killer cells
Immunology & Cell Biology (2011)
-
Functions of skin-resident γδ T cells
Cellular and Molecular Life Sciences (2011)